241 related articles for article (PubMed ID: 25734338)
1. Attenuation of tick-borne encephalitis virus using large-scale random codon re-encoding.
de Fabritus L; Nougairède A; Aubry F; Gould EA; de Lamballerie X
PLoS Pathog; 2015 Mar; 11(3):e1004738. PubMed ID: 25734338
[TBL] [Abstract][Full Text] [Related]
2. Utilisation of ISA Reverse Genetics and Large-Scale Random Codon Re-Encoding to Produce Attenuated Strains of Tick-Borne Encephalitis Virus within Days.
de Fabritus L; Nougairède A; Aubry F; Gould EA; de Lamballerie X
PLoS One; 2016; 11(8):e0159564. PubMed ID: 27548676
[TBL] [Abstract][Full Text] [Related]
3. Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus.
Tsetsarkin KA; Maximova OA; Liu G; Kenney H; Teterina NL; Pletnev AG
mBio; 2019 Apr; 10(2):. PubMed ID: 31015334
[TBL] [Abstract][Full Text] [Related]
4. Infectious cDNA clone of attenuated Langat tick-borne flavivirus (strain E5) and a 3' deletion mutant constructed from it exhibit decreased neuroinvasiveness in immunodeficient mice.
Pletnev AG
Virology; 2001 Apr; 282(2):288-300. PubMed ID: 11289811
[TBL] [Abstract][Full Text] [Related]
5. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
[TBL] [Abstract][Full Text] [Related]
6. Generation and Characterization of a Chimeric Tick-Borne Encephalitis Virus Attenuated Strain ChinTBEV.
Wang HJ; Li XF; Qin CF
Methods Mol Biol; 2016; 1403():285-93. PubMed ID: 27076137
[TBL] [Abstract][Full Text] [Related]
7. A tick-borne Langat virus mutant that is temperature sensitive and host range restricted in neuroblastoma cells and lacks neuroinvasiveness for immunodeficient mice.
Rumyantsev AA; Murphy BR; Pletnev AG
J Virol; 2006 Feb; 80(3):1427-39. PubMed ID: 16415020
[TBL] [Abstract][Full Text] [Related]
8. Safety evaluation of chimeric Langat/Dengue 4 flavivirus, a live vaccine candidate against tick-borne encephalitis.
Pripuzova NS; Tereshkina NV; Gmyl LV; Dzhivanyan TI; Rumyantsev AA; Romanova LIu; Mustafina AN; Lashkevich VA; Karganova GG
J Med Virol; 2009 Oct; 81(10):1777-85. PubMed ID: 19697399
[TBL] [Abstract][Full Text] [Related]
9. Recombinant chimeric Japanese encephalitis virus/tick-borne encephalitis virus is attenuated and protective in mice.
Wang HJ; Li XF; Ye Q; Li SH; Deng YQ; Zhao H; Xu YP; Ma J; Qin ED; Qin CF
Vaccine; 2014 Feb; 32(8):949-56. PubMed ID: 24394443
[TBL] [Abstract][Full Text] [Related]
10. A BHK-21 cell culture-adapted tick-borne encephalitis virus mutant is attenuated for neuroinvasiveness.
Goto A; Hayasaka D; Yoshii K; Mizutani T; Kariwa H; Takashima I
Vaccine; 2003 Sep; 21(25-26):4043-51. PubMed ID: 12922141
[TBL] [Abstract][Full Text] [Related]
11. [Use of inbred mice for assessing the neurovirulence of strains of the tick-borne encephalitis virus complex and the immunogenicity of a concentrated tick-borne encephalitis vaccine].
Kan GA; Borsuk EA; Vorob'eva MS
Vopr Virusol; 1982; 27(4):461-4. PubMed ID: 7135927
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of the Langat tick-borne flavivirus by chimerization with mosquito-borne flavivirus dengue type 4.
Pletnev AG; Men R
Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1746-51. PubMed ID: 9465088
[TBL] [Abstract][Full Text] [Related]
13. Chimeric Langat/Dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus.
Pletnev AG; Karganova GG; Dzhivanyan TI; Lashkevich VA; Bray M
Virology; 2000 Aug; 274(1):26-31. PubMed ID: 10936085
[TBL] [Abstract][Full Text] [Related]
14. Recombinant domains III of Tick-Borne Encephalitis Virus envelope protein in combination with dextran and CpGs induce immune response and partial protectiveness against TBE virus infection in mice.
Ershova AS; Gra OA; Lyaschuk AM; Grunina TM; Tkachuk AP; Bartov MS; Savina DM; Sergienko OV; Galushkina ZM; Gudov VP; Kozlovskaya LI; Kholodilov IS; Gmyl LV; Karganova GG; Lunin VG; Karyagina AS; Gintsburg AL
BMC Infect Dis; 2016 Oct; 16(1):544. PubMed ID: 27717318
[TBL] [Abstract][Full Text] [Related]
15. Insertion of microRNA targets into the flavivirus genome alters its highly neurovirulent phenotype.
Heiss BL; Maximova OA; Pletnev AG
J Virol; 2011 Feb; 85(4):1464-72. PubMed ID: 21123372
[TBL] [Abstract][Full Text] [Related]
16. [Characteristics of neurovirulence, stability, and immunogenicity of attenuated variants of TP-21 Langat virus].
Sokolova ED; Kamalov II; Konovalov GV
Vopr Virusol; 1994; 39(5):220-3. PubMed ID: 7716907
[TBL] [Abstract][Full Text] [Related]
17. Synergistic Internal Ribosome Entry Site/MicroRNA-Based Approach for Flavivirus Attenuation and Live Vaccine Development.
Tsetsarkin KA; Liu G; Volkova E; Pletnev AG
mBio; 2017 Apr; 8(2):. PubMed ID: 28420742
[TBL] [Abstract][Full Text] [Related]
18. The degree of attenuation of tick-borne encephalitis virus depends on the cumulative effects of point mutations.
Gritsun TS; Desai A; Gould EA
J Gen Virol; 2001 Jul; 82(Pt 7):1667-1675. PubMed ID: 11413378
[TBL] [Abstract][Full Text] [Related]
19. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis.
Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS
J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392
[TBL] [Abstract][Full Text] [Related]
20. Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis.
Lai CJ; Monath TP
Adv Virus Res; 2003; 61():469-509. PubMed ID: 14714441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
